Key result
Whole-exome sequencing links a novel LMNA mutation to inherited cardiac conduction disease.
Why the study?
Does whole-exome sequencing identify causal mutations in families with inherited cardiac conduction disease?
Observational (n=257)
Does whole-exome sequencing identify causal mutations in families with inherited cardiac conduction disease?
Answers are grounded in this paper and cite their sources.
Whole-exome sequencing successfully identified a novel LMNA mutation (G232V) as the causal genetic defect in a family with inherited cardiac conduction disease.
BACKGROUND: Inherited cardiac conduction diseases (CCD) are rare but are caused by mutations in a myriad of genes. Recently, whole-exome sequencing has successfully led to the identification of causal mutations for rare monogenic Mendelian diseases. OBJECTIVE: To investigate the genetic background of a family affected by inherited CCD. METHODS AND RESULTS: We used whole-exome sequencing to study a Chinese family with multiple family members affected by CCD. Using the pedigree information, we proposed a heterozygous missense mutation (c.G695T, Gly232Val) in the lamin A/C (LMNA) gene as a candidate mutation for susceptibility to CCD in this family. The mutation is novel and is expected to affect the conformation of the coiled-coil rod domain of LMNA according to a structural model prediction. Its pathogenicity in lamina instability was further verified by expressing the mutation in a cellular model. CONCLUSIONS: Our results suggest that whole-exome sequencing is a feasible approach to identifying the candidate genes underlying inherited conduction diseases.
No takes yet. Share an insight, caveat, or question.
Lai et al. (2013) conducted an observational in Inherited cardiac conduction disease (n=257). LMNA gene mutation (c.G695T, Gly232Val) vs. Wild-type LMNA / Unexposed controls was evaluated on Identification of causal genetic mutation for inherited cardiac conduction disease. Whole-exome sequencing identified a novel heterozygous missense mutation (c.G695T, Gly232Val) in the LMNA gene that co-segregates with inherited cardiac conduction disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: